Krystal Biotech (KRYS) Asset Utilization Ratio (2023 - 2026)
Krystal Biotech (KRYS) posted quarterly Asset Utilization Ratio of 0.3 for Q2 2026, down 6.34% year-over-year from 0.32 in Q2 2025, and down 0.52% on a QoQ basis from 0.31 in Q1 2026.
Krystal Biotech (KRYS) Asset Utilization Ratio (2023 - 2026) Analysis & Trends
Krystal Biotech has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.3 in Q2 2026.
- Asset Utilization Ratio for Q2 2026 came in at 0.3, down 6.34% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.3 (down 6.34% YoY), and the FY2025 annual result was 0.33, up 5.05% from the prior year.
- Asset Utilization Ratio fell to 0.3 in Q2 2026, from 0.31 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.32 in Q2 2025 and troughed at 0.01 in Q3 2023.
- A 4-year average of 0.23 and a median of 0.29 in 2024 frame the typical range for Asset Utilization Ratio.
- The widest annual swing landed in 2024, when Asset Utilization Ratio soared 2091.09%; it then dropped 6.34% in 2026.
- A 4-year view of Asset Utilization Ratio shows it stood at 0.06 in 2023, then surged by 352.34% to 0.29 in 2024, then climbed by 6.06% to 0.3 in 2025, then increased by 0.56% to 0.3 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.3 in Q2 2026, 0.31 in Q1 2026, and 0.3 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn | 0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.30 |
| Mar 31, 2026 | 0.31 |
| Dec 31, 2025 | 0.30 |
| Sep 30, 2025 | 0.31 |
| Jun 30, 2025 | 0.32 |
| Mar 31, 2025 | 0.31 |
| Dec 31, 2024 | 0.29 |
| Sep 30, 2024 | 0.25 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.01 |